Trials / Completed
CompletedNCT05275556
Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,410 (actual)
- Sponsor
- Verily Life Sciences LLC · Industry
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective, multicenter, randomized controlled study to evaluate the effect of the Computer-Assisted Detection (CADe) Device on Adenomas Per Colonoscopy and Positive Percent Agreement for routine colonoscopies. The control arm is colonoscopy performed with High Definition White Light Endoscopy (HD-WLE) per standard of care. The intervention arm is colonoscopy performed with HD-WLE per standard of care plus the Computer-Assisted Detection (CADe) Device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Computer-Assisted Detection (CADe) Device | The CADe Device uses artificial intelligence to aid in identifying colorectal polyps during High Definition White Light Endoscopy (HD-WLE) based colonoscopies. This device connects the Gastroenterologist's colonoscopy video output source to the main monitor and highlights the regions of interest where the device detects a potential lesion. The CADe Device overlays graphical markers onto video from the endoscope camera and does not perform further processing to the endoscope video signal. This device is not intended to replace clinical decision making. |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-10-28
- Completion
- 2022-10-28
- First posted
- 2022-03-11
- Last updated
- 2025-01-14
- Results posted
- 2025-01-14
Locations
7 sites across 2 countries: United States, Israel
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05275556. Inclusion in this directory is not an endorsement.